Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts

American Journal of Drug and Alcohol Abuse

Volumn 35, Issue 5, 2009, Pages 267-272

  Shi, Jie ^a   Li, Su Xia ^a   Zhang, Xiao Li ^a   Wang, Xi ^a   Foll, Bernard Le ^b   Zhang, Xiang Yang ^c   Kosten, Thomas R ^c   Lu, Lin ^a  

^a PEKING UNIVERSITY   (China)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

ACTH; Beta endorphin; Cortisol; Drug craving; Heroin abstainers; Leptin; Neuropeptide Y

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; DIAMORPHINE; HYDROCORTISONE; LEPTIN; NEUROPEPTIDE Y;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DEPRESSION; DRUG USE; DRUG WITHDRAWAL; HEROIN DEPENDENCE; HUMAN; MALE; NEUROENDOCRINE SYSTEM; TIME; WITHDRAWAL SYNDROME;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANALYSIS OF VARIANCE; ANXIETY; BETA-ENDORPHIN; CASE-CONTROL STUDIES; DEPRESSION; HEROIN; HEROIN DEPENDENCE; HUMANS; HYDROCORTISONE; LEPTIN; MALE; NEUROPEPTIDE Y; NEUROSECRETORY SYSTEMS; PATIENT SELECTION; PSYCHIATRIC STATUS RATING SCALES; RADIOIMMUNOASSAY; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 77249091342     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990902933878     Document Type: Article

References (38)

1. Koob GF. Neurobiology of addiction. Toward the development of new therapies. Ann N Y Acad Sci 2000; 909:170-185.
2. Shi J, Zhao LY, Epstein DH, Zhang XL, Lu L. Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cueinduced craving in Chinese heroin abusers. Pharmacol Biochem Behav 2007; 87(1):141-145.
3. Cohen LJ, Gertmenian-King E,Kunik L,WeaverC, London ED,Galynker I. Personality measures in former heroin users receiving methadone or in protracted abstinence from opiates. Acta Psychiatr Scand 2005; 112(2):149-158.
4. O'Connor PG, Fiellin DA. Pharmacologic treatment of heroin-dependent patients. Ann Intern Med 2000; 133(1):40-54.
5. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science 1997; 278(5335):58-63.
6. Goeders NE. Stress and cocaine addiction. J Pharmacol Exp Ther 2002; 301(3):785-789.
7. Kreek MJ, Koob GF. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 1998; 51(1-2):23-47.
8. Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) 2001; 158(4):343-359.
9. Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) 2003; 170(1):62-72.
10. Sarnyai Z, Shaham Y, Heinrichs SC. The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 2001; 53(2):209-243.
11. Piazza PV, Le Moal ML. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 1996; 36:359-378.
12. Koob G, Kreek MJ. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 2007; 164(8):1149-1159.
13. Kreek MJ, Wardlaw SL, Hartman N, Raghunath J, Friedman J, Schneider B, Frantz AG. Circadian rhythms and levels of beta-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans. Life Sci 1983; 33(Suppl 1):409-411.
14. Cushman P Jr., Kreek MJ. Methadone-maintained patients. Effect of methadone on plasma testosterone, FSH, LH, and prolactin. N Y State J Med 1974; 74(11):1970-1973.
15. Cami J, Gilabert M, San L, de la Torre R. Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts. Br J Addict 1992; 87(8):1145-1151.
16. Bearn J, Buntwal N, Papadopoulos A, Checkley S. Salivary cortisol during opiate dependence and withdrawal. Addict Biol 2001; 6(2):157-162.
17. Shalev U, Yap J, Shaham Y. Leptin attenuates acute food deprivationinduced relapse to heroin seeking. J Neurosci 2001; 21(4):RC129.
18. Kiefer F,Wiedemann K. Neuroendocrine pathways of addictive behaviour. Addict Biol 2004; 9(3-4):205-212.
19. Kosten TR, Markou A, Koob GF. Depression and stimulant dependence: neurobiology and pharmacotherapy. J Nerv Ment Dis 1998; 186(12):737-745.
20. Gil-Ad I, Bar-Yoseph J, Smadja Y, Zohar M, Laron Z. Effect of clonidine on plasma beta-endorphin, cortisol and growth hormone secretion in opiate-addicted subjects. Isr J Med Sci 1985; 21(7):601-604.
21. O'Brien CP, Terenius LY, Nyberg F, McLellan AT, Eriksson I. Endogenous opioids in cerebrospinal fluid of opioid-dependent humans. Biol Psychiatry 1988; 24(6):649-662.
22. Housova J, Wilczek H, Haluzik MM, Kremen J, Krizova J, Haluzik M. Adipocyte-derived hormones in heroin addicts: The influence of methadone maintenance treatment. Physiol Res 2005; 54(1):73-78.
23. Wilczek H, Haluzik M, Svobodova J, Parizkova J. Serum leptin levels in patients with heroin addiction, the effect of one year of methadone substitution. Vnitr Lek 2004; 50(4):282-285.
24. Weiss F. Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol 2005; 5(1):9-19.
25. Rittmaster RS, Cutler GB Jr, Sobel DO, Goldstein DS, Koppelman MC, Loriaux DL, Chrousos GP. Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. J Clin Endocrinol Metab 1985; 60(5):891-895.
26. Gerra G, Ceresini S, Esposito A, Zaimovic A, Moi G, Bussandri M, Raggi MA,Molina E. Neuroendocrine and behavioural responses to opioid receptor-antagonist during heroin detoxification: relationship with personality traits. Int Clin Psychopharmacol 2003; 18(5):261-269.
27. Kennedy JA, Hartman N, Sbriglio R, Khuri E, Kreek MJ. Metyraponeinduced withdrawal symptoms. Br J Addict 1990; 85(9):1133-1140.
28. Wisniewski AB, Brown TT, John M, Cofranceso J Jr, Golub ET, Ricketts EP, Wand G, Dobs AS. Cortisol levels and depression in men and women using heroin and cocaine. Psychoneuroendocrinology 2006; 31(2):250-255.
29. Wen HL, Ho WK, Wong HK, Mehal ZD, Ng YH, Ma L. Changes in adrenocorticotropic hormone (ACTH) and cortisol levels in drug addicts treated by a new and rapid detoxification procedure using acupuncture and naloxone. Comp Med East West 1979; 6(3):241-245.
30. Vescovi PP, Gerra G, Maninetti L, Pedrazzoni M, Michelini M, Pioli G, Girasole G, Caccavari R, Maestri D, Passeri M. Metyrapone effects on beta-endorphin, ACTH and cortisol levels after chronic opiate receptor stimulation in man. Neuropeptides 1990; 15(3):129-132.
31. Kiefer F, Horntrich M, Jahn H, Wiedemann K. Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Psychopharmacology (Berl) 2002; 162(4):433-437.
32. Wen HL, Ho WK, Ling N, Mehal ZD, Ng YH. Immunoassayable betaendorphin level in the plasma and CSF of heroin addicted and normal subjects before and after electroacupuncture. Am J Chin Med 1980; 8(1- 2):154-159.
33. Ho WK, Wen HL, Ling N. Beta-endorphin-like immunoactivity in the plasma of heroin addicts and normal subjects. Neuropharmacology 1980; 19(1):117-120.
34. Wen HL, Ho WK, Wen PY. Comparison of the effectiveness of different opioid peptides in suppressing heroin withdrawal. Eur J Pharmacol 1984; 100(2):155-162.
35. Su CY, Lin CS, Peng C, Cheng CS, Loh HH, Li CH, Way EL. Suppression of morphine abstinence in heroin addicts by beta-endorphin. Adv Biochem Psychopharmacol 1980; 22:503-509.
36. Cavagnini F, Croci M, Putignano P, Petroni ML, Invitti C. Glucocorticoids and neuroendocrine function. Int J Obes Relat Metab Disord 2000; 24(Suppl 2):S77-79.
37. Clausen TR, Moller M, Woldbye DP. Inhibitory effect of neuropeptide Y on morphine withdrawal is accompanied by reduced c-fos expression in specific brain regions. J Neurosci Res 2001; 64(4):410-417.
38. Olson VG, Griner NB, Heusner CL, Palmiter RD. Lack of neuropeptide Y attenuates the somatic signs of opiate withdrawal. Synapse 2006; 60(7):553-556.